This inventor holds 1 USPTO granted patent. Top assignee: Kukje Pharma Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Shinyoung Lee: Innovator in Pharmaceutical Composition
Introduction
Shinyoung Lee is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Shinyoung Lee holds a patent for an indole carboxamide derivative and a pharmaceutical composition containing the same. This patent describes indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salts that inhibit the production of prostaglandin E (PGE) through the inhibition of microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and their salts are effective in treating or preventing various conditions, including inflammation, arthritis, high fever, pain, cancer, stroke, and neurodegenerative diseases such as Alzheimer's disease. A pharmaceutical composition that includes the indole carboxamide compound as an active ingredient is also part of this patent.
Career Highlights
Shinyoung Lee is associated with Kukje Pharma Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research and development efforts have positioned him as a key player in the industry.
Collaborations
Shinyoung Lee collaborates with talented individuals such as Younghoon Kim and Juhee Lee, contributing to a dynamic research environment that fosters innovation.
Conclusion
Shinyoung Lee's work in developing indole carboxamide derivatives showcases his commitment to advancing pharmaceutical science. His contributions have the potential to significantly impact the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile